1. Academic Validation
  2. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2

Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2

  • Am J Hum Genet. 2009 Jan;84(1):44-51. doi: 10.1016/j.ajhg.2008.12.009.
Derek E Neilson 1 Mark D Adams Caitlin M D Orr Deborah K Schelling Robert M Eiben Douglas S Kerr Jane Anderson Alexander G Bassuk Ann M Bye Anne-Marie Childs Antonia Clarke Yanick J Crow Maja Di Rocco Christian Dohna-Schwake Gregor Dueckers Alfonso E Fasano Artemis D Gika Dimitris Gionnis Mark P Gorman Padraic J Grattan-Smith Annette Hackenberg Alice Kuster Markus G Lentschig Eduardo Lopez-Laso Elysa J Marco Sotiria Mastroyianni Julie Perrier Thomas Schmitt-Mechelke Serenella Servidei Angeliki Skardoutsou Peter Uldall Marjo S van der Knaap Karrie C Goglin David L Tefft Cristin Aubin Philip de Jager David Hafler Matthew L Warman
Affiliations

Affiliation

  • 1 Department of Genetics, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center, Cleveland, OH 44106, USA. derek.neilson@cchmc.org
Abstract

Acute necrotizing encephalopathy (ANE) is a rapidly progressive encephalopathy that can occur in otherwise healthy children after common viral infections such as influenza and parainfluenza. Most ANE is sporadic and nonrecurrent (isolated ANE). However, we identified a 7 Mb interval containing a susceptibility locus (ANE1) in a family segregating recurrent ANE as an incompletely penetrant, autosomal-dominant trait. We now report that all affected individuals and obligate carriers in this family are heterozygous for a missense mutation (c.1880C-->T, p.Thr585Met) in the gene encoding the nuclear pore protein Ran Binding Protein 2 (RANBP2). To determine whether this mutation is the susceptibility allele, we screened controls and other patients with ANE who are unrelated to the index family. Patients from 9 of 15 additional kindreds with familial or recurrent ANE had the identical mutation. It arose de novo in two families and independently in several other families. Two other patients with familial ANE had different RANBP2 missense mutations that altered conserved residues. None of the three RANBP2 missense mutations were found in 19 patients with isolated ANE or in unaffected controls. We conclude that missense mutations in RANBP2 are susceptibility alleles for familial and recurrent cases of ANE.

Figures